Repositori DSpace/Manakin

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Mostra el registre parcial de l'element

dc.creator Wong, Florence
dc.creator Bernardi, Mauro
dc.creator Balk, R.
dc.creator Christman, B.
dc.creator Moreau, Richard
dc.creator Garcia-Tsao, G.
dc.creator Patch, D.
dc.creator Soriano Pastor, Germán
dc.creator Hoefs, J.
dc.creator Navasa, Miquel
dc.date 2011-07-07T12:31:04Z
dc.date 2011-07-07T12:31:04Z
dc.date 2005
dc.date.accessioned 2024-12-16T10:27:16Z
dc.date.available 2024-12-16T10:27:16Z
dc.identifier 0017-5749
dc.identifier http://hdl.handle.net/2445/18680
dc.identifier 552296
dc.identifier 15831923
dc.identifier.uri http://fima-docencia.ub.edu:8080/xmlui/handle/123456789/22182
dc.description Sepsis is a systemic inflammatory response to the presence of infection, mediated via the production of many cytokines, including tumour necrosis factor ¿ (TNF-¿), interleukin (IL)-6, and IL-1, which cause changes in the circulation and in the coagulation cascade. There is stagnation of blood flow and poor oxygenation, subclinical coagulopathy with elevated D-dimers, and increased production of superoxide from nitric oxide synthase. All of these changes favour endothelial apoptosis and necrosis as well as increased oxidant stress. Reduced levels of activated protein C, which is normally anti-inflammatory and antiapoptotic, can lead to further tissue injury. Cirrhotic patients are particularly susceptible to bacterial infections because of increased bacterial translocation, possibly related to liver dysfunction and reduced reticuloendothelial function. Sepsis ensues when there is overactivation of pathways involved in the development of the sepsis syndrome, associated with complications such as renal failure, encephalopathy, gastrointestinal bleed, and shock with decreased survival. Thus the treating physician needs to be vigilant in diagnosing and treating bacterial infections in cirrhosis early, in order to prevent the development and downward spiral of the sepsis syndrome. Recent advances in management strategies of infections in cirrhosis have helped to improve the prognosis of these patients. These include the use of prophylactic antibiotics in patients with gastrointestinal bleed to prevent infection and the use of albumin in patients with spontaneous bacterial peritonitis to reduce the incidence of renal impairment. The use of antibiotics has to be judicious, as their indiscriminate use can lead to antibiotic resistance with potentially disastrous consequences.
dc.format 8 p.
dc.format application/pdf
dc.language eng
dc.publisher BMJ Group
dc.relation Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.2004.038679
dc.relation Gut, 2005, vol. 54, núm. 5, p. 718-725
dc.relation http://dx.doi.org/10.1136/gut.2004.038679
dc.rights (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2005
dc.rights info:eu-repo/semantics/openAccess
dc.source Articles publicats en revistes (Medicina)
dc.subject Cirrosi hepàtica
dc.subject Infeccions
dc.subject Septicèmia
dc.subject Hepatic cirrhosis
dc.subject Infections
dc.subject Septicemia
dc.title Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

Fitxers Grandària Format Visualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a DSpace


Cerca avançada

Visualitza

El meu compte